These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11053913)

  • 41. Chemical analysis of constitutive pigmentation of human epidermis reveals constant eumelanin to pheomelanin ratio.
    Del Bino S; Ito S; Sok J; Nakanishi Y; Bastien P; Wakamatsu K; Bernerd F
    Pigment Cell Melanoma Res; 2015 Nov; 28(6):707-17. PubMed ID: 26285058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduction in the appearance of facial hyperpigmentation after use of moisturizers with a combination of topical niacinamide and N-acetyl glucosamine: results of a randomized, double-blind, vehicle-controlled trial.
    Kimball AB; Kaczvinsky JR; Li J; Robinson LR; Matts PJ; Berge CA; Miyamoto K; Bissett DL
    Br J Dermatol; 2010 Feb; 162(2):435-41. PubMed ID: 19845667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The skin-depigmenting potential of Paeonia lactiflora root extract and paeoniflorin: in vitro evaluation using reconstructed pigmented human epidermis.
    Qiu J; Chen M; Liu J; Huang X; Chen J; Zhou L; Ma J; Sextius P; Pena AM; Cai Z; Jeulin S
    Int J Cosmet Sci; 2016 Oct; 38(5):444-51. PubMed ID: 26826350
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions.
    Seiberg M; Paine C; Sharlow E; Andrade-Gordon P; Costanzo M; Eisinger M; Shapiro SS
    Exp Cell Res; 2000 Jan; 254(1):25-32. PubMed ID: 10623462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of skin pigmentation by an extract of Lepidium apetalum and its possible implication in IL-6 mediated signaling.
    Choi H; Ahn S; Lee BG; Chang I; Hwang JS
    Pigment Cell Res; 2005 Dec; 18(6):439-46. PubMed ID: 16280009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-melanogenic effects of Aster spathulifolius extract in UVB-exposed C57BL/6J mice and B16F10 melanoma cells through the regulation of MAPK/ERK and AKT/GSK3β signalling.
    Hwang GY; Choung SY
    J Pharm Pharmacol; 2016 Apr; 68(4):503-13. PubMed ID: 26993057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The mechanism of action and clinical benefits of soy for the treatment of hyperpigmentation.
    Leyden J; Wallo W
    Int J Dermatol; 2011 Apr; 50(4):470-7. PubMed ID: 21332714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical evaluation of the depigmenting effect of Glechoma Hederacea extract by topical treatment for 8 weeks on UV-induced pigmentation in Asian skin.
    Ha JH; Kang WH; Lee JO; Cho YK; Park SK; Lee SK; Cho HK
    Eur J Dermatol; 2011; 21(2):218-22. PubMed ID: 21411411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tyrosinase inhibition by extracts and constituents of Sideroxylon inerme L. stem bark, used in South Africa for skin lightening.
    Momtaz S; Mapunya BM; Houghton PJ; Edgerly C; Hussein A; Naidoo S; Lall N
    J Ethnopharmacol; 2008 Oct; 119(3):507-12. PubMed ID: 18573327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Yucatan miniature swine as a model for post-inflammatory hyperpigmentation.
    Wang Y; Herringshaw E; Anderson RR; Tam J
    Pigment Cell Melanoma Res; 2024 May; 37(3):403-410. PubMed ID: 38361478
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eruptive Facial Postinflammatory Lentigo: Clinical and Dermatoscopic Features.
    Cabrera R; Puig S; Larrondo J; Castro A; Valenzuela K; Sabatini N
    Am J Dermatopathol; 2016 Nov; 38(11):813-819. PubMed ID: 27362605
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hyperpigmentation of the face].
    Szekeres E; Korom I; Zombai E
    Hautarzt; 1990 Mar; 41(3):164-7. PubMed ID: 2345101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical evaluation of the lightening effect of cytidine on hyperpigmented skin.
    Baswan SM; Leverett J; Pawelek J
    J Cosmet Dermatol; 2019 Feb; 18(1):278-285. PubMed ID: 30291682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A case of idiopathic eruptive macular pigmentation.
    Yoon TY; Lee GC; Kim YG; Kim MK; Kim CY
    J Dermatol; 2004 May; 31(5):440-1. PubMed ID: 15187318
    [No Abstract]   [Full Text] [Related]  

  • 55. The assessment of the effect of a cosmetic product brightening the skin of people with discolorations of different etiology.
    Zasada M; Debowska R; Pasikowska M; Budzisz E
    J Cosmet Dermatol; 2016 Dec; 15(4):493-502. PubMed ID: 27349716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colorimetric assessment of the effects of azelaic acid on light-induced skin pigmentation.
    Duteil L; Ortonne JP
    Photodermatol Photoimmunol Photomed; 1992 Apr; 9(2):67-71. PubMed ID: 1489719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural ingredients for darker skin types: growing options for hyperpigmentation.
    Alexis AF; Blackcloud P
    J Drugs Dermatol; 2013 Sep; 12(9 Suppl):s123-7. PubMed ID: 24002160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blockade of melanin synthesis, activation and distribution pathway by a nonprescription natural regimen is equally effective to a multiple prescription-based therapeutic regimen.
    Thornfeldt C; Rizer RL; Trookman NS
    J Drugs Dermatol; 2013 Dec; 12(12):1449-54. PubMed ID: 24301247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel Anti-Melanogenesis Properties of Polydeoxyribonucleotide, a Popular Wound Healing Booster.
    Noh TK; Chung BY; Kim SY; Lee MH; Kim MJ; Youn CS; Lee MW; Chang SE
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27598132
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An evaluation of the effect of a topical product containing C-xyloside and blueberry extract on the appearance of type II diabetic skin.
    Draelos ZD; Yatskayer M; Raab S; Oresajo C
    J Cosmet Dermatol; 2009 Jun; 8(2):147-51. PubMed ID: 19527341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.